Afatinib Dimaleate and Capecitabine in Treating Patients With Advanced Refractory Solid Tumors, Pancreatic Cancer or Biliary Cancer

Clinical trial NCT02451553 · COMPLETED

Trial details

NCT number: NCT02451553
Sponsor: University of Washington
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Solid Neoplasm Bile Duct Carcinoma Recurrent Malignant Solid Neoplasm Recurrent Pancreatic Carcinoma Stage III Pancreatic Cancer AJCC v6 and v7 Stage IVA Pancreatic Cancer Stage IVB Pancreatic Cancer

Start date: 2015-11-05
Primary completion: 2022-04-16
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.